Rchr
J-GLOBAL ID：201101060640316313
Update date: Nov. 01, 2024
Kadomatsu Tsuyoshi
カドマツ ツヨシ | Kadomatsu Tsuyoshi
Contact this researcher
You can send email directly to the researcher.
Affiliation and department：
Kumamoto University
About Kumamoto University
Search "Kumamoto University"
Detailed information
Job title：
Assistant Professor
Research field (1)：
Pathobiochemistry
Research keywords (2)：
分子遺伝学
, molecular genetics
Research theme for competitive and other funds (1)：
2013 - 2016 Molecular mechanism of diabetes mellitus based on beta-cell transcription factor network
Papers (73)：
Tomoya Yamashita, Haruki Horiguchi, Tsuyoshi Kadomatsu, Michio Sato, Toshiro Moroishi, Yuichi Oike. Immunotherapy-induced reprogramming of cancer-associated fibroblasts can promote tumor progression. Genes to cells : devoted to molecular & cellular mechanisms. 2024
Shinsei Yumoto, Haruki Horiguchi, Tsuyoshi Kadomatsu, Taichi Horino, Michio Sato, Kazutoyo Terada, Keishi Miyata, Toshiro Moroishi, Hideo Baba, Yuichi Oike. Host ANGPTL2 establishes an immunosuppressive tumor microenvironment and resistance to immune checkpoint therapy. Cancer science. 2024
Taichi Horino, Haruki Horiguchi, Shinsei Yumoto, Tsuyoshi Kadomatsu, Yoshihiro Hara, Taisuke Yagi, Yoshifumi Baba, Yuji Miyamoto, Hideo Baba, Yuichi Oike. Angiopoietin-Like Protein 2 Expression in Tumor Cells Supports Tumor-Associated Macrophage-Induced Tumor Progression in Esophageal Cancer. Annals of surgical oncology. 2024
Haruki Horiguchi, Tsuyoshi Kadomatsu, Tomoya Yamashita, Shinsei Yumoto, Taichi Horino, Michio Sato, Kazutoyo Terada, Keishi Miyata, Yuki Ichigozaki, Toshihiro Kimura, et al. Tumor stroma-derived ANGPTL2 potentiates immune checkpoint inhibitor efficacy. Cancer gene therapy. 2024
Hirotaka Fukami, Jun Morinaga, Hironori Nakagami, Hiroki Hayashi, Yusuke Okadome, Eiji Matsunaga, Tsuyoshi Kadomatsu, Haruki Horiguchi, Michio Sato, Taichi Sugizaki, et al. Efficacy and safety in mice of repeated, lifelong administration of an ANGPTL3 vaccine. npj Vaccines. 2023. 8. 1
ｍore...
MISC (46)：
門松 毅, 尾池 雄一. ミトコンドリア機能恒常性維持の変容と加齢関連疾患. 実験医学 増刊. 2023. 41. 5. 126-131
門松 毅, 尾池 雄一. 【アンチエイジング科学と未来医療】心不全とRNA創薬. Precision Medicine. 2022. 5. 13. 1188-1191
村上 慶高, 中條 岳志, 魏 范研, 堀口 晴紀, 門松 毅, 尾池 雄一, 安東 由喜雄, 植田 光晴, 富澤 一仁. ミトコンドリアtRNA修飾酵素NSUN3の全身および心臓における生理的意義の解明. 日本生理学雑誌. 2022. 84. 1. 18-19
門松 毅. 老化における慢性炎症とサルコペニア. 別冊 BIO Clinica 慢性炎症と疾患. 2021. 10. 27. 52-56
門松 毅, 尾池 雄一. 【老化、加齢疾患研究を俯瞰し、健康長寿社会実現の夢を開く】Seminar エネルギー代謝の変容・破綻と加齢疾患. Geriatric Medicine. 2021. 59. 7. 689-692
ｍore...
Books (2)：
論文図表を読む作法 : はじめて出会う実験&解析法も正しく解釈! : 生命科学・医学論文をスラスラ読むためのFigure事典
羊土社 2022 ISBN:9784758122603
膨大なデータを徹底整理する サイトカイン・増殖因子キーワード事典
羊土社 2015
Lectures and oral presentations (1)：
SASP 因子ANGPTL2 による抗腫瘍免疫逃避機構
(第24回日本抗加齢医学会総会 2024)
Professional career (1)：
博士(医学) (熊本大学)
Work history (5)：
2020 - 現在 Kumamoto University
2013 - 2020 Kumamoto University Faculty of Life Sciences
2013 - 2020 Assistant Professor,Faculty of Life Sciences(Basic medicine group),Kumamoto University
2010 - 2013 Kumamoto University Faculty of Life Sciences
2010 - 2013 Assistant Professor,Faculty of Life Sciences(Basic medicine group),Kumamoto University
Association Membership(s) (3)：
THE MOLECULAR BIOLOGY SOCIETY OF JAPAN
, THE JAPANESE BIOCHEMICAL SOCIETY
, THE JAPANESE CANCER ASSOCIATION
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM
